Lamotrigine Tablet, Film Coated, Extended Release
Product Images NDC 31722-245

15 FDA label images from Camber Pharmaceuticals Inc · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 15 technical images submitted to the FDA as part of the official labeling for Lamotrigine (NDC 31722-245). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Camber Pharmaceuticals Inc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical Structure (Graphic 01)

Chemical Structure (Graphic 01)
Chemical structure diagram of lamotrigine, showing the molecular arrangement with chlorine atoms, amino groups, and a fused ring system.*
FDA Label Image

Figure 1. Proportion Of Patients By Responder Rate For Lamotrigine And Placebo Group (primary Generalized Tonic-clonic Seizures Study) (Figure 1)

Figure 1.  Proportion Of Patients By Responder Rate For Lamotrigine And Placebo Group (primary Generalized Tonic-clonic Seizures Study) (Figure 1)
A responder rate curve comparing lamotrigine extended-release and placebo. The graph shows the percentage of patients on the x-axis against responder rate (equal or greater improvement vs worsening) on the y-axis. Two lines represent the treatment group (lamotrigine) and placebo, showing differences in patient response rates.*
FDA Label Image

Figure 2. Proportion Of Patients By Responder Rate For Lamotrigine And Placebo Group (partial-onset Seizure Study) (Figure 2)

Figure 2. Proportion Of Patients By Responder Rate For Lamotrigine And Placebo Group (partial-onset Seizure Study) (Figure 2)
A line graph comparing responder rates between lamotrigine extended-release and placebo groups. The x-axis shows percent of patients from 100 to 0, and the y-axis shows responder rate from worsening (-100%) to improvement (100%). Two lines represent placebo (dashed) and lamotrigine (solid) response rates, illustrating treatment effects in a patient population.*
FDA Label Image

25 mg Tab (25mg Picture)

25 mg Tab (25mg Picture)
The image shows a round, white extended-release film-coated tablet imprinted with 'Y31'. This tablet corresponds to lamotrigine extended-release oral tablets manufactured by Camber Pharmaceuticals Inc. Strength or other specifics are not visible on the tablet itself in the image.*
FDA Label Image

50 mg Tab (50mg Picture)

50 mg Tab (50mg Picture)
The image shows a round, white, film-coated extended-release tablet of lamotrigine with the imprint "Y32". This tablet is identifiable as one of the available strengths for lamotrigine extended-release, a prescription drug by Camber Pharmaceuticals Inc., intended for oral use.*
FDA Label Image

100 mg Tab (100mg Picture)

100 mg Tab (100mg Picture)
The image shows a round, white film-coated tablet imprinted with "Y33" on one side. This tablet corresponds to lamotrigine extended-release. The imprint helps identify the medication, which is orally administered in extended-release tablet form, distributed by Camber Pharmaceuticals Inc.*
FDA Label Image

200 mg Tab (200mg Picture)

200 mg Tab (200mg Picture)
Lamotrigine extended-release 100 mg film-coated tablet with imprint 'Y34' on one side. Circular white tablet used for oral administration. Manufactured by Camber Pharmaceuticals Inc.*
FDA Label Image

250 mg Tab (250mg Picture)

250 mg Tab (250mg Picture)
The image shows an oval, film-coated extended-release tablet embossed with "Y35" on one side. This tablet corresponds to lamotrigine extended-release, a prescription oral medication available in various strengths including 100 mg and 200 mg, manufactured by Camber Pharmaceuticals Inc.*
FDA Label Image

300 mg Tab (300mg Picture)

300 mg Tab (300mg Picture)
The image shows a white, oval, film-coated extended-release tablet with the imprint "Y36". This tablet corresponds to lamotrigine extended-release, available in various strengths including 100 mg, 200 mg, 25 mg, 250 mg, 300 mg, and 50 mg, and is labeled by Camber Pharmaceuticals Inc.*
FDA Label Image

Label-25mg 30tablets (Label 25mg 30tablets)

Label-25mg 30tablets (Label 25mg 30tablets)
Packaging label for Lamotrigine Extended-Release Tablets USP 25 mg by Camber Pharmaceuticals Inc. The label includes dosage strength (25 mg), quantity (30 tablets), and storage instructions. It contains the NDC 31722-240-30, barcode, and cautions regarding the safety seal and medication guide dispensing.*
FDA Label Image

Label-50mg 30tablets (Label 50mg 30tablets)

Label-50mg 30tablets (Label 50mg 30tablets)
Label for Lamotrigine Extended-Release Tablets, USP 50 mg oral tablets by Camber Pharmaceuticals Inc. The label includes a green and white design with dosing caution, storage information, and a barcode. The package contains 30 tablets, labeled as prescription-only (Rx only). Manufacturer information and a website for medication guides are also present.*
FDA Label Image

Label-100mg 30tablets (Label 100mg 30tablets)

Label-100mg 30tablets (Label 100mg 30tablets)
Label for Lamotrigine Extended-Release Tablets USP, 100 mg strength, film-coated tablets. The label states a 30-tablet count, prescription-only (Rx) drug, manufactured for Camber Pharmaceuticals Inc. The label includes storage instructions, a caution to verify the product dispensed, and a note to dispense the Medication Guide separately. A barcode and manufacturing details from Yiling Pharmaceutical Ltd, China, are visible.*
FDA Label Image

Label-200mg 30tablets (Label 200mg 30tablets)

Label-200mg 30tablets (Label 200mg 30tablets)
Label for Lamotrigine Extended-Release Tablets USP 200 mg, oral film-coated tablets. The label includes the NDC number 31722-243-30 and states the product is for prescription use only with 30 tablets per bottle. It is manufactured by Camber Pharmaceuticals Inc with distribution by Yiling Pharmaceutical Ltd, China. The label also contains storage instructions, a caution to verify the product dispensed, and a medication guide URL.*
FDA Label Image

Label-250mg 30tablets (Label 250mg 30tablets)

Label-250mg 30tablets (Label 250mg 30tablets)
Label for Lamotrigine Extended-Release Tablets, USP 250 mg from Camber Pharmaceuticals Inc. The label includes dosage instructions 'Once A Day' and packaging details for 30 tablets. It features a caution to verify the product dispensed and to provide the medication guide separately. Storage conditions and a barcode are also shown.*
FDA Label Image

Label-300mg 30tablets (Label 300mg 30tablets)

Label-300mg 30tablets (Label 300mg 30tablets)
Label for Lamotrigine Extended-Release Tablets USP 300 mg by Camber Pharmaceuticals Inc. The label includes dosage strength prominently in blue, a warning to verify the product dispensed, storage instructions, barcode, and manufacturing information including location in China. The label states the product is prescription only and contains 30 tablets in the package.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.